Heparan sulphate proteoglycans and diabetic nephropathy.
van der Woude
F J
FJ
V. Medizinische Klinik, Klinikum Mannheim, Germany. woude@rumms.uni-mannheim.de
van Det
N F
NF
D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D003928:Diabetic Nephropathies / Q000209:etiology* / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007678:Kidney Glomerulus / Q000378:metabolism; D011509:Proteoglycans / Q000737:chemistry / Q000378:metabolism*; D016212:Transforming Growth Factor beta / Q000378:metabolism
D000804:Angiotensin II; D016222:Fibroblast Growth Factor 2; D019812:Heparan Sulfate Proteoglycans; D006497:Heparan Sulfate; D011509:Proteoglycans; D016212:Transforming Growth Factor beta